Report Description

India Remdesivir market is anticipated to grow with an impressive CAGR in the forecast period, FY2023-FY2027. The market has shown a consistent growth in the last five years and it is expected to grow with the projected cumulative annular growth rate on the account of increasing prevalence of COVID-19 patients and the surge in the demand of drugs to overcome the viral infection. Moreover, the chronic diseases are rapidly increasing in the country, with changing lifestyle and the life choice of the population, the Remdesivir market in India is expected to grow in the upcoming five years. Also, India has a large number of geriatric populations, that is more prone to infectious diseases which in turn, is influencing the growth of India Remdesivir market growth, positively.

Remdesivir is an antiviral medication that is developed by the biopharmaceutical company Gilead Sciences. Administered via injection into a vein, the drug manufacturing process started in March 2020 with a research performed by Gilead Sciences Inc. The research was performed on 53 prospective COVID-19 patients out of which only 36 patients showed signs of progress that accounted for about 68% of the total number of patients. World Health Organization has guided the start of clinical trials for the drug along with three other drugs found to be effective in COVID-19 therapy. Remdesivir drug has reached phase 3 of clinical trials and the world hopes it will emerge as a promising treatment for COVID-19. Following these positive trials, the food and drug administration issued permission for the medication to treat Covid-19 for emergency use authorization (EUA). That means the medication has not undergone the same examination as therapies approved by the FDA, but it will allow doctors to prescribe Remdesivir to patients hospitalized with the disease. All supply of drugs will go to the government for allocation across the nation.

India Remdesivir market segmentations is based on application, route of administration, dosage form, patient age, distribution channel, competitional landscape, and regional distribution. Based on application, the market is further bifurcated into Ebola, SARS-COV, MERS-COV, COVID-19. Ebola is anticipated to hold the largest revenue shares of the market and assert its dominance over the market segment in the upcoming five years, on the account of surge in infections caused due to the virus. COVID-19 is anticipated to register the fastest growing CAGR growth in the upcoming five years. The pandemic caused due to outbreak of viral infection has surged the number of patients to multiple folds. Moreover, the country is still under the threat of new variant of the virus that is continuously claiming lives and the drug Remdesivir is expected to help with the treatment, and thus supports the growth of the India Remdesivir market in the next five years.

Some of the top players in the India Remdesivir Market are, Cipla Ltd., Hetero Labs Pvt. Ltd., Jubilant Life Sciences Ltd., Viatris Pharmaceuticals Ltd. (Mylan Laboratories India Pvt. Ltd.), Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Zydus Cadila Healthcare Ltd., Pfizer Ltd., Gilead Sciences India Private Limited, Eva Pharma Pvt. Ltd., among others. The companies are involving themselves into research and development for more advanced form of the drug. Remdesivir is the therapeutic drug against the coronavirus, COVID-19 and are in demand owing to the need of the healthcare industry in the country. Although the export of the drug is increasing rapidly to satisfy the consumer demand. New players entering the market may form partnerships with other players or the end users of the industry for a consistent inflow of the product.

Years considered for this report:

Historical Years: FY2017 – FY2020

Base Year: FY2021

Estimated Year: FY2022

Forecast Period: FY2023 – FY2027

Objective of the Study:

  • To analyze the historical growth of the market size of India Remdesivir market from FY2017 to FY2020.
  • To estimate and forecast the market size of India Remdesivir market from FY2021 to FY2027 and growth rate until FY2027. 
  • To classify and forecast India Remdesivir market based on application, route of administration, dosage form, patient age, distribution channel, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the India Remdesivir market.
  • To identify drivers and challenges for India Remdesivir market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India Remdesivir market.
  • To identify and analyze the profile of leading players operating in India Remdesivir market.
  • To identify key sustainable strategies adopted by market players in India Remdesivir market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of India Remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Remdesivir manufacturers, end users, and other stakeholders
  • Distributers and suppliers of Remdesivir and other stakeholders
  • Organizations, forums and alliances related to coronavirus drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India Remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • India Remdesivir Market, By Application:
    • Ebola
    • SARS-COV
    • MERS-COV
    • COVID-19
  • India Remdesivir Market, By Route of Administration:

o   Inhalation

o   Intravenous

  • India Remdesivir Market, By Dosage Form:

o   Frozen Solution

o   Lypholized Solution

  • India Remdesivir Market, By Patient Age:
    • Pediatric (12 years or older)
    • Adult
    • Geriatric
  • India Remdesivir Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Drug Stores/Pharmacies
  • India Remdesivir Market, By Region:
    • South
    • West
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India Remdesivir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
India Remdesivir Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.     Product of Interest Introduction: Remdesivir Market

2.    Research Methodology

3.    Impact of COVID-19 on India Remdesivir Market

4.    Executive Summary

5.    Voice of Customers/Customer Insights

6.    India Remdesivir Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value and By Volume

6.2.  Market Share & Forecast

6.2.1.     By Application (Ebola, SARS-COV, MERS-COV, COVID-19)

6.2.2.     By Route of Administration (Inhalation v/s Intravenous)

6.2.3.     By Dosage Form (Frozen Solution, Lypholized Solution)

6.2.4.     By Patient Age (Pediatric (12 years or older), Adult, Geriatric)

6.2.5.     By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies)

6.2.6.     By Company (FY2021)

6.2.7.     By Region

6.3.  Product Market Map

7.    North Remdesivir Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value and By Volume

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By Route of Administration

7.2.3.     By Dosage Form

7.2.4.     By Patient Age

7.2.5.     By Distribution Channel

8.    South India Remdesivir Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value and By Volume

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By Route of Administration

8.2.3.     By Dosage Form

8.2.4.     By Patient Age

8.2.5.     By Distribution Channel

9.    East India Remdesivir Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value and By Volume

9.2.  Market Share & Forecast

9.2.1.     By Application

9.2.2.     By Route of Administration

9.2.3.     By Dosage Form

9.2.4.     By Patient Age

9.2.5.     By Distribution Channel

10.  West India Remdesivir Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value and By Volume

10.2.              Market Share & Forecast

10.2.1.     By Application

10.2.2.  By Route of Administration

10.2.3.  By Dosage Form

10.2.4.  By Patient Age

10.2.5.  By Distribution Channel

11.  Market Dynamics

11.1.              Drivers/Opportunities

11.2.              Challenges/Restraints

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  India Economic Profile

15.  Competitive Landscape

15.1.              Company Profiles

15.1.1.  Cipla Ltd.

15.1.2.  Hetero Labs Pvt. Ltd.

15.1.3.  Jubilant Life Sciences Ltd.

15.1.4.  Viatris Pharmaceuticals Ltd. (Mylan Laboratories India Pvt. Ltd.)

15.1.5.  Dr. Reddy’s Laboratories Ltd.

15.1.6.  Sun Pharmaceuticals Industries Ltd.

15.1.7.  Zydus Cadila Healthcare Ltd.

15.1.8.  Pfizer Ltd.

15.1.9.  Gilead Sciences India Private Limited

15.1.10.                Eva Pharma Pvt. Ltd.

16.  Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Frequently asked questions